Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 212,548 shares at $22.74 ($4.9M) on 2019-11-01, disclosed to the SEC on 2019-11-04.
Open-market sale of $4.9M NEO by President, Clinical Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.11 | 70,473 | $1.6M | 33.3% |
| 2 | $23.11 | 70,473 | $1.6M | 33.3% |
| 3 | $22.74 | 35,801 | $814K | 16.7% |
| 4 | $22.74 | 35,801 | $814K | 16.7% |
| Total | $22.99 avg | 212,548 | $4.9M | 100% |
| Filing → |
| NEO | SELL | 2020-03-05 | $6.1M | — | Filing → |
| NEO | SELL | 2019-05-06 | $5.3M | — | Filing → |
| NEO | SELL | 2019-02-28 | $7.1M | — | Filing → |